Koppers Holdings Inc (KOP) Stock Price

28.22 ▲ +0.61 (+2.21%)
Open: 27.58 Vol: 125.03K Day's range: 27.095 - 28.3899 Oct 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KOP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 28.23▲ 28.16▲ 28.14▲ 28.77▼ 27.49▲
MA10 28.17▲ 28.09▲ 27.85▲ 28.51▼ 28.15▲
MA20 28.15▲ 27.82▲ 28.36▼ 27.55▲ 30.03▼
MA50 28.07▲ 28.68▼ 28.84▼ 28.18▲ 30.17▼
MA100 27.97▲ 28.78▼ 27.93▲ 30.19▼ 37.01▼
MA200 28.67▼ 27.77▲ 27.68▲ 29.55▼ 33.87▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.007▲ 0.109▲ 0.032▲ 0.172▲ -0.164▼
RSI 61.739▲ 52.014▲ 46.902▼ 51.307▲ 45.397▼
STOCH 88.100▲ 82.776▲ 74.615     72.509     28.073    
WILL %R -8.696▲ -3.960▲ -29.197     -43.912     -75.834▼
CCI 120.238▲ 79.522     62.893     -2.164     -27.214    
Latest Filters Detected On KOP
RSI $KOP RSI(14) Crossed Above 50 Set Alert
MA $KOP Price Crossed Above MA(50) Set Alert
MA $KOP Price Crossed Above MA(13) Set Alert
Koppers Holdings Inc News
NASDAQ: FFIV Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages F5, Inc. (NASDAQ: FFIV) Investors With Significant Losses to Contact the Firm
Friday, October 31, 2025 04:56 PM
RADNOR, PA - October 31, 2025 ( NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com) is currently investigating potential violations of the federal securities laws on ...
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
Friday, October 31, 2025 07:40 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary ...
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
Friday, October 31, 2025 07:27 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio ...
KOP historical stock data
date open high low close volume
31/10/25 27.58 28.3899 27.095 28.22 125,026
30/10/25 28.67 28.67 27.2595 27.61 162,612
29/10/25 29.38 29.825 28.82 29.25 219,510
28/10/25 29.19 29.59 28.85 29.37 139,406
27/10/25 29.36 29.63 28.96 29.41 152,006
24/10/25 29.12 29.44 29.07 29.14 85,600
23/10/25 28.62 29.02 28.42 28.72 104,670
22/10/25 28.00 28.44 27.935 28.38 145,003
21/10/25 27.02 28.03 27.00 27.99 153,347
20/10/25 26.92 27.145 26.57 27.01 119,246
Quote Details
52wk Low:22.99
52wk High:39.83
Vol:125.03K
Avg Vol(3m):3.6M
1Y Chng:-22.60%
1M Chng:-2.32%
Add to Watch List
More Information
Index S&P 600
Market Cap. 544.35M